Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126523192 | 12652319 | 2 | F | 20160825 | 20160815 | 20160830 | EXP | PHHY2016AR111484 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160830 | CN | COUNTRY NOT SPECIFIED | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126523192 | 12652319 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 2 DF, Q12H | Y | 22068 | 2 | DF | CAPSULE | Q12H | |||||
| 126523192 | 12652319 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 1 DF (1 CAPSULE AT 12:00 AT NOON), QD | Y | 22068 | 1 | DF | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126523192 | 12652319 | 1 | Chronic myeloid leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126523192 | 12652319 | Flushing | |
| 126523192 | 12652319 | Pruritus | |
| 126523192 | 12652319 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |